Table 3.

Differences in Haematological neoplasm related deaths for Sarcoidosis patients and the general Spanish population by lineage.

	Neoplasm-related deaths N (%)			Mean age (years), (SD)
	Non-sarcoidosis	Sarcoidosis	p	Non-sarcoidosis	Sarcoidosis	p	OR (95% CI)a
Haematological	12,362 (8.9)	16 (20.5)	0.001	71.9 (15.5)	63.6 (12.5)	0.032	2.64 (1.52–4.59)
Malign haematological	11,993 (8.6)	14 (18.4)	0.006	71.7 (15.6)	62.32 (12.8)	0.023	2.30 (1.28–4.11)
Lymphoma	4241 (3)	7 (9.2)	0.008	70.7 (14.7)	56.9 (14)	0.013	3.09 (1.42–6.73)
Hodgkin Lymphoma	261 (0.2)	0	1	65.5 (18.4)	–	–	–
Non-Hodgkin Lymphoma	3980 (2.9)	7 (9.2)	0.006	71 (14.4)	56.9 (14)	0.009	3.33 (1.53–7.25)
B cell lineage	3541 (2.5)	5 (6.6)	0.044	71.7 (14.2)	59 (10.1)	0.046	2.62 (1.06–6.50)
T/NK cell lineage	439 (0.3)	2 (2.6)	0.024	65.6 (14.6)	51.5 (26.1)	0.174	7.88 (1.92–32.29)
Leukemia	4627 (3.3)	4 (5.3)	0.322	70.2 (18.1)	70.5 (10.8)	0.972	1.50 (0.55–4.10)
Myeloid lineage	3193 (2.3)	2 (2.6)	0.694	71.2 (15.5)	61.5 (0.71)	0.377	1.09 (0.27–4.45)
Lymphoid lineage	1005 (0.7)	1 (1.3)	0.423	64.7 (24.3)	83	0.452	1.56 (0.22–11.30)
Multiple myeloma	2163 (1.6)	2 (2.6)	0.342	74 (11)	68 (5.7)	0.445	1.70 (0.42–6.93)
Myelodisplastic syndrome	885 (0.6)	1 (1.3)	0.384	78.7 (12)	55	0.049	2.37 (0.33–17.16)
Others	77 (0.1)	0	1	71 (17.1)	–	–	–
Unknown behaviour	369 (0.3)	2 (2.6)	0.018	79 (10.5)	73	0.419	11.88 (2.88–49.02)
Myeloproliferative disorders	242 (0.2)	1 (1.3)	0.124	78.4 (10.1)	75	0.592
Others	127 (0.1)	1 (1.3)	0.067	80.2 (11.3)	73	0.528	-

SD: Standard deviation, OR: Odds ratio, CI: Confidence interval.

Values in bold highlight statistically significant differences.

^aAfter adjustment for age, sex, alcohol and tobacco consumption.